Company profile AXNX
After 38 days of this quarter the interest is at 227.0. Based on that we can calculate that during remaining 53 days it will total up to 544.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 57 | 91 59.6% QoQ | 135 48.4% QoQ | 159 17.8% QoQ |
| 2020 | 165 189.5% YoY 3.8% QoQ | 128 40.7% YoY -22.4% QoQ | 154 14.1% YoY 20.3% QoQ | 166 4.4% YoY 7.8% QoQ |
| 2021 | 158 -4.2% YoY -4.8% QoQ | 186 45.3% YoY 17.7% QoQ | 173 12.3% YoY -7.0% QoQ | 202 21.7% YoY 16.8% QoQ |
| 2022 | 204 29.1% YoY 1.0% QoQ | 441 137.1% YoY 116.2% QoQ | 505 191.9% YoY 14.5% QoQ | 542 168.3% YoY 7.3% QoQ |
| 2023 | 472 131.4% YoY -12.9% QoQ | 453 2.7% YoY -4.0% QoQ | 451 -10.7% YoY -0.4% QoQ | 588 8.5% YoY 30.4% QoQ |
| 2024 | 227 -51.9% YoY -61.4% QoQ | - | - | - |
The average 5 years interest of Axonics was 21.76 per week. The last year interest of Axonics compared to the last 5 years has changed by 78.17%. The interest for Axonics is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 289.26%.
There is not enough data for Axonics Axonics stock to provide analysis
There is not enough data for Axonics Axonics stock to provide correlation calculation
There is not enough data for Axonics Axonics stock to provide analysis
After 38 days of this quarter the interest is at 63.0. Based on that we can calculate that during remaining 53 days it will total up to 151.0. bladder dysfunction treatment expected interest is significantly higher compared to previous quarter (+43.8%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 67 | 158 135.8% QoQ | 135 -14.6% QoQ | 202 49.6% QoQ |
| 2020 | 102 52.2% YoY -49.5% QoQ | 58 -63.3% YoY -43.1% QoQ | 24 -82.2% YoY -58.6% QoQ | 102 -49.5% YoY 325.0% QoQ |
| 2021 | 32 -68.6% YoY -68.6% QoQ | 123 112.1% YoY 284.4% QoQ | 145 504.2% YoY 17.9% QoQ | 182 78.4% YoY 25.5% QoQ |
| 2022 | 245 665.6% YoY 34.6% QoQ | 71 -42.3% YoY -71.0% QoQ | 180 24.1% YoY 153.5% QoQ | 141 -22.5% YoY -21.7% QoQ |
| 2023 | 229 -6.5% YoY 62.4% QoQ | 127 78.9% YoY -44.5% QoQ | 86 -52.2% YoY -32.3% QoQ | 105 -25.5% YoY 22.1% QoQ |
| 2024 | 63 -72.5% YoY -40.0% QoQ | - | - | - |
The average 5 years interest of bladder dysfunction treatment was 9.91 per week. The last year interest of bladder dysfunction treatment compared to the last 5 years has changed by -11.5%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -23.34%.
There is not enough data for bowel dysfunction treatment to provide analysis
There is not enough data for bowel dysfunction treatment to provide correlation calculation
There is not enough data for bowel dysfunction treatment to provide analysis
After 38 days of this quarter the interest is at 51.0. Based on that we can calculate that during remaining 53 days it will total up to 122.0. sacral neuromodulation expected interest is significantly lower compared to previous quarter (-77.9%) and same quarter last year (-73.8%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 68 | 138 102.9% QoQ | 187 35.5% QoQ | 277 48.1% QoQ |
| 2020 | 232 241.2% YoY -16.2% QoQ | 229 65.9% YoY -1.3% QoQ | 511 173.3% YoY 123.1% QoQ | 365 31.8% YoY -28.6% QoQ |
| 2021 | 316 36.2% YoY -13.4% QoQ | 389 69.9% YoY 23.1% QoQ | 210 -58.9% YoY -46.0% QoQ | 457 25.2% YoY 117.6% QoQ |
| 2022 | 314 -0.6% YoY -31.3% QoQ | 392 0.8% YoY 24.8% QoQ | 338 61.0% YoY -13.8% QoQ | 341 -25.4% YoY 0.9% QoQ |
| 2023 | 465 48.1% YoY 36.4% QoQ | 470 19.9% YoY 1.1% QoQ | 600 77.5% YoY 27.7% QoQ | 552 61.9% YoY -8.0% QoQ |
| 2024 | 51 -89.0% YoY -90.8% QoQ | - | - | - |
The average 5 years interest of sacral neuromodulation was 26.55 per week. The last year interest of sacral neuromodulation compared to the last 5 years has changed by 34.09%. The interest for sacral neuromodulation is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 122.78%.
After 38 days of this quarter the interest is at 162.0. Based on that we can calculate that during remaining 53 days it will total up to 388.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 270 | 433 60.4% QoQ | 512 18.2% QoQ | 408 -20.3% QoQ |
| 2020 | 468 73.3% YoY 14.7% QoQ | 347 -19.9% YoY -25.9% QoQ | 628 22.7% YoY 81.0% QoQ | 507 24.3% YoY -19.3% QoQ |
| 2021 | 530 13.2% YoY 4.5% QoQ | 588 69.5% YoY 10.9% QoQ | 436 -30.6% YoY -25.9% QoQ | 520 2.6% YoY 19.3% QoQ |
| 2022 | 522 -1.5% YoY 0.4% QoQ | 462 -21.4% YoY -11.5% QoQ | 475 8.9% YoY 2.8% QoQ | 624 20.0% YoY 31.4% QoQ |
| 2023 | 588 12.6% YoY -5.8% QoQ | 597 29.2% YoY 1.5% QoQ | 438 -7.8% YoY -26.6% QoQ | 528 -15.4% YoY 20.5% QoQ |
| 2024 | 162 -72.4% YoY -69.3% QoQ | - | - | - |
The average 5 years interest of overactive bladder treatment was 38.63 per week. The last year interest of overactive bladder treatment compared to the last 5 years has changed by 4.5%. The interest for overactive bladder treatment is seasonal. The last year interest is comparable to 5 years ago. It has changed only by 14.95%.
There is not enough data for urinary urge incontinence treatment to provide analysis
There is not enough data for urinary urge incontinence treatment to provide correlation calculation
There is not enough data for urinary urge incontinence treatment to provide analysis
There is not enough data for urinary urgency frequency treatment to provide analysis
There is not enough data for urinary urgency frequency treatment to provide correlation calculation
There is not enough data for urinary urgency frequency treatment to provide analysis
After 38 days of this quarter the interest is at 150.0. Based on that we can calculate that during remaining 53 days it will total up to 359.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 121 | 241 99.2% QoQ | 114 -52.7% QoQ | 304 166.7% QoQ |
| 2020 | 359 196.7% YoY 18.1% QoQ | 203 -15.8% YoY -43.5% QoQ | 192 68.4% YoY -5.4% QoQ | 148 -51.3% YoY -22.9% QoQ |
| 2021 | 256 -28.7% YoY 73.0% QoQ | 167 -17.7% YoY -34.8% QoQ | 167 -13.0% YoY 0.0% QoQ | 431 191.2% YoY 158.1% QoQ |
| 2022 | 180 -29.7% YoY -58.2% QoQ | 349 109.0% YoY 93.9% QoQ | 309 85.0% YoY -11.5% QoQ | 240 -44.3% YoY -22.3% QoQ |
| 2023 | 354 96.7% YoY 47.5% QoQ | 574 64.5% YoY 62.1% QoQ | 131 -57.6% YoY -77.2% QoQ | 504 110.0% YoY 284.7% QoQ |
| 2024 | 150 -57.6% YoY -70.2% QoQ | - | - | - |
The average 5 years interest of fecal incontinence treatment was 21.13 per week. The last year interest of fecal incontinence treatment compared to the last 5 years has changed by 43.54%. The interest for fecal incontinence treatment is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 69.92%.
There is not enough data for non-obstructive urinary retention treatment to provide analysis
There is not enough data for non-obstructive urinary retention treatment to provide correlation calculation
There is not enough data for non-obstructive urinary retention treatment to provide analysis
There is not enough data for rechargeable SNM system to provide analysis
There is not enough data for rechargeable SNM system to provide correlation calculation
There is not enough data for rechargeable SNM system to provide analysis
There is not enough data for recharge-free SNM system to provide analysis
There is not enough data for recharge-free SNM system to provide correlation calculation
There is not enough data for recharge-free SNM system to provide analysis
There is not enough data for mild electrical pulses to provide analysis
There is not enough data for mild electrical pulses to provide correlation calculation
There is not enough data for mild electrical pulses to provide analysis
After 38 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 53 days it will total up to 0.0. bladder and bowel dysfunction expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 138 | 253 83.3% QoQ | 180 -28.9% QoQ | 226 25.6% QoQ |
| 2020 | 159 15.2% YoY -29.6% QoQ | 63 -75.1% YoY -60.4% QoQ | 112 -37.8% YoY 77.8% QoQ | 47 -79.2% YoY -58.0% QoQ |
| 2021 | 215 35.2% YoY 357.4% QoQ | 166 163.5% YoY -22.8% QoQ | 209 86.6% YoY 25.9% QoQ | 108 129.8% YoY -48.3% QoQ |
| 2022 | 396 84.2% YoY 266.7% QoQ | 133 -19.9% YoY -66.4% QoQ | 256 22.5% YoY 92.5% QoQ | 255 136.1% YoY -0.4% QoQ |
| 2023 | 229 -42.2% YoY -10.2% QoQ | 97 -27.1% YoY -57.6% QoQ | 264 3.1% YoY 172.2% QoQ | 46 -82.0% YoY -82.6% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of bladder and bowel dysfunction was 13.66 per week. The last year interest of bladder and bowel dysfunction compared to the last 5 years has changed by -23.72%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -34.63%.
After 38 days of this quarter the interest is at 319.0. Based on that we can calculate that during remaining 53 days it will total up to 764.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 22 | 52 136.4% QoQ | 72 38.5% QoQ | 21 -70.8% QoQ |
| 2020 | 23 4.5% YoY 9.5% QoQ | 41 -21.2% YoY 78.3% QoQ | 85 18.1% YoY 107.3% QoQ | 41 95.2% YoY -51.8% QoQ |
| 2021 | 80 247.8% YoY 95.1% QoQ | 244 495.1% YoY 205.0% QoQ | 282 231.8% YoY 15.6% QoQ | 296 622.0% YoY 5.0% QoQ |
| 2022 | 438 447.5% YoY 48.0% QoQ | 540 121.3% YoY 23.3% QoQ | 692 145.4% YoY 28.1% QoQ | 721 143.6% YoY 4.2% QoQ |
| 2023 | 790 80.4% YoY 9.6% QoQ | 789 46.1% YoY -0.1% QoQ | 800 15.6% YoY 1.4% QoQ | 993 37.7% YoY 24.1% QoQ |
| 2024 | 319 -59.6% YoY -67.9% QoQ | - | - | - |
The average 5 years interest of Bulkamid was 28.23 per week. The last year interest of Bulkamid compared to the last 5 years has changed by 134.33%. The interest for Bulkamid is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 1874.63%.
There is not enough data for urethral bulking agent to provide analysis
There is not enough data for urethral bulking agent to provide correlation calculation
There is not enough data for urethral bulking agent to provide analysis